Evermay Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126K Hold
884
– – 0.01% 249
2026
Q2
$139K Buy
884
+258
+41% +$38.7K 0.01% 237
2026
Q1
$95.6K Sell
626
-490
-44% -$75.1K 0.01% 254
2025
Q4
$154K Sell
1,116
-48
-4% -$6.29K 0.02% 221
2025
Q3
$149K Hold
1,164
– – 0.02% 227
2025
Q2
$141K Hold
1,164
– – 0.02% 232
2025
Q1
$130K Hold
1,164
– – 0.02% 232
2024
Q4
$113K Sell
1,164
-12
-1% -$1.28K 0.02% 245
2024
Q3
$135K Hold
1,176
– – 0.02% 236
2024
Q2
$125K Hold
1,176
– – 0.02% 241
2024
Q1
$114K Buy
1,176
+100
+9% +$10.3K 0.02% 265
2023
Q4
$109K Hold
1,076
– – 0.02% 250
2023
Q3
$110K Hold
1,076
– – 0.02% 225
2023
Q2
$109K Buy
1,076
+467
+77% +$46.7K 0.02% 231
2023
Q1
$56K Hold
609
– – 0.01% 292
2022
Q4
$55.2K Buy
609
+276
+83% +$23.2K 0.01% 290
2022
Q3
$25K Hold
333
– – 0.01% 329
2022
Q2
$28K Hold
333
– – 0.01% 318
2022
Q1
$29K Hold
333
– – ﹤0.01% 342
2021
Q4
$29K Hold
333
– – 0.01% 328
2021
Q3
$27K Hold
333
– – 0.01% 317
2021
Q2
$30K Buy
+333
New +$29.7K 0.01% 330
2014
Q4
– Sell
-2,570
Closed -$217K – 90
2014
Q3
$217K Sell
2,570
-34
-1% -$2.75K 0.19% 74
2014
Q2
$211K Buy
+2,604
New +$205K 0.18% 77

Other funds holding NVS

Evermay Wealth Management's NVS Position: Q3 2026 in Review

Evermay Wealth Management held its Novartis (NVS) position steady in Q3 2026 at 884 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #249.

Evermay Wealth Management first reported a position in NVS in Q2 2014 and has held it in 24 quarters since. The position peaked at $217K in Q3 2014. 995 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Evermay Wealth Management held 884 shares of Novartis worth $126K as of Q3 2026.
  • Evermay Wealth Management left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.01% of Evermay Wealth Management's portfolio in Q3 2026, its #249 holding.
  • Evermay Wealth Management first reported a position in Novartis in Q2 2014 and has held it in 24 quarters since.
  • Evermay Wealth Management's Novartis position peaked at $217K in Q3 2014.
  • 995 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Evermay Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.